The buying on the counter came after the company received World Health Organization (WHO) prequalification approval for Amodiaquine Hydrochloride USP
At 01:38 pm; the stock was up 13% at Rs 231, the top gainer among the S&P BSE Smallcap index.
Pre-qualification is a process under which drug companies have to fulfil certain WHO-stipulated conditions